News

The COVID-19 pandemic accelerated the adoption of virtual consultations (VC) in the United Kingdom’s National Health Service (NHS) cancer genetics services. This transition aimed to address increasing waiting times for cancer care, exacerbated by the pandemic. Virtual care platforms were implemented to prevent further delays and optimize patient outcomes.

One of the key opportunities offered by VC is the potential to alleviate geographical inequalities in accessing cancer genetics services. Patients residing in rural areas often face travel costs and inconvenience when accessing specialized centers located far away. VC provides a feasible alternative, especially since more households have internet access than means of transportation.

In terms of economics and efficacy, studies have shown that virtual genetic counseling for cancer genetics appointments can save time and cost. This is mainly due to reduced travel time. Virtual services also offer flexibility, which can result in efficiencies in managing urgent work or accommodating clinicians who need to self-isolate.

Patient expectations are changing as technology becomes more integrated into daily life. VC can help mitigate the financial impact of cancer treatment by reducing time off work or school. It also provides the comfort, safety, and privacy of home, which is particularly beneficial for immunocompromised patients. Post-COVID-19, acceptance for virtual appointments has significantly increased.

Virtual healthcare models also contribute to reducing the carbon footprint by minimizing transport. This aligns with the NHS’s long-term carbon net zero plan to provide care closer to home.

VCs enable a family-centric approach to genetic testing by allowing relatives to participate in sessions from different locations. This can be facilitated through platforms that merge virtual consultations, enabling family counseling irrespective of geographical boundaries.

However, there are challenges to consider. A portion of the population lacks the necessary digital skills and access, which may impede virtual healthcare access among disadvantaged groups. Clinicians also vary in their digital literacy, and technical issues during virtual consultations can occur. Providing adequate resources and infrastructure is essential, along with regular updates to data handling procedures.

VC limits the clinician’s ability to conduct physical examinations, which can be necessary in cancer genetics services. Secure integration of patient-submitted photographs via mobile apps may offer further possibilities in this regard.

Confidentiality and coercion can be issues in telehealth consultations, and delivering sensitive news digitally may present challenges in conveying empathy. However, studies have shown that virtual platforms do not inherently hinder empathy or emotional outcomes.

The decision between telephone and video consultations depends on patient preference and technical considerations. Workload management is crucial, ensuring balanced schedules for clinicians and managing patient expectations effectively.

Overall, the adoption of virtual consultations in cancer genetics services during the COVID-19 pandemic presents opportunities and challenges. It is essential to address digital barriers and ensure adequate resources are in place to optimize patient outcomes and provide effective care.

The post The Role of Virtual Consultations in Cancer Genetics: Opportunities and Challenges During the COVID-19 Pandemic appeared first on satProviders.